Trexquant Investment LP trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 62.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,309 shares of the healthcare conglomerate's stock after selling 13,714 shares during the period. Trexquant Investment LP's holdings in UnitedHealth Group were worth $4,352,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Gerber Kawasaki Wealth & Investment Management grew its stake in UnitedHealth Group by 7.0% in the first quarter. Gerber Kawasaki Wealth & Investment Management now owns 1,258 shares of the healthcare conglomerate's stock valued at $659,000 after acquiring an additional 82 shares during the period. Landscape Capital Management L.L.C. grew its stake in UnitedHealth Group by 19.6% in the first quarter. Landscape Capital Management L.L.C. now owns 13,262 shares of the healthcare conglomerate's stock valued at $6,946,000 after acquiring an additional 2,173 shares during the period. Oarsman Capital Inc. grew its stake in UnitedHealth Group by 4.7% in the first quarter. Oarsman Capital Inc. now owns 4,967 shares of the healthcare conglomerate's stock valued at $2,602,000 after acquiring an additional 224 shares during the period. Okabena Investment Services Inc. lifted its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Okabena Investment Services Inc. now owns 4,504 shares of the healthcare conglomerate's stock valued at $2,359,000 after purchasing an additional 64 shares in the last quarter. Finally, OMERS ADMINISTRATION Corp lifted its holdings in shares of UnitedHealth Group by 57.3% in the first quarter. OMERS ADMINISTRATION Corp now owns 269,089 shares of the healthcare conglomerate's stock valued at $140,935,000 after purchasing an additional 97,968 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
Insider Activity at UnitedHealth Group
In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.28% of the company's stock.
UnitedHealth Group Price Performance
Shares of NYSE UNH opened at $309.77 on Tuesday. The business's 50 day moving average price is $288.34 and its two-hundred day moving average price is $378.14. The company has a market cap of $280.55 billion, a PE ratio of 13.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.44. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio is presently 38.30%.
Wall Street Analyst Weigh In
A number of analysts have recently commented on UNH shares. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Wells Fargo & Company cut their price target on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Truist Financial cut their price target on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. Finally, HSBC reiterated a "reduce" rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $353.00.
Check Out Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.